prnewswire.com May. 28, 2019
Growth At Flagship Pioneering Leads To New Executive Appointments
CAMBRIDGE, Mass., May 28, 2019 /PRNewswire/ -- Flagship Pioneering, a unique life sciences innovation enterprise, today announced the expansion of its...
xconomy.com Apr. 16, 2019
Flagship Pioneering Unveils Kintai’S Gut Approach To Treating Disease
The gastrointestinal system is often viewed as a barrier to drugs. Conditions ideal for breaking down food also break down drugs in ways that can limit
massdevice.com Mar. 20, 2019
Boston VC Shop Flagship Pioneering Raises $824M With 8Th Fund
Life-sciences focused venture capital group Flagship Pioneering said today that it raised $824 million for its new Special Opportunities Fund II, which aims to support companies created by its Flagship Labs unit. The funds join an existing capital pool of more than $700 million Flagship said it raised between late 2017 and 2018 to finance …
wsj.com Mar. 20, 2019
Flagship Pioneering Rounds Up $824 Million Special Opportunities Fund
Flagship Pioneering has closed an $824 million fund aimed at maturing companies from its portfolio of life sciences holdings, an effort to profit from the value startups create as their technologies yield new products.
businesswire.com Jan. 18, 2019
Dr. John Mendlein To Transition To An Advisory Role At Moderna And Join Flagship Pioneering As An Executive Partner
John Mendlein, Ph.D., President of Corporate and Product Strategy, will be leaving Moderna to join Flagship Pioneering as an Executive Partner.
equitiesfocus.com Sep. 8, 2018
Flagship Pioneering Inc. Buys New Stake In Evelo Biosciences Inc (EVLO)
Flagship Pioneering Inc. acquired a new position in Evelo Biosciences Inc (NASDAQ:EVLO) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 18,233,403 shares of the company’s stock, valued at approximately $215,154,000. Evelo Biosciences accounts for about 41.2% of Flagship Pioneering Inc.’s holdings, making the stock […]